Glenn Saldanha, managing director and CEO of Glenmark Pharmaceuticals, in an interview with CNBC-TV18's Udayan Mukherjee and Mitali Mukherjee, said that its business in India is growing at 23-24%, while its business in US is expected to grow 25% in FY12.
first published: May 11, 2011 10:46 am
A collection of the most-viewed Moneycontrol videos.
Point-to-Point vs Rolling Returns for Mutual Funds: Full Breakdown
From Hesitant Heir to Undisputed Leader: Sanjiv Bajaj's Leadership Story
Nifty Fails To Defend 26,000 Amid Sluggish Start To Final Week Of 2025| Closing Bell Live
Nifty Aims To Defend 26,000 Amid Thin Volumes, Record-Low VIX| Opening Bell Live
